Company / Working Capital per Share
Veracyte, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.51
FY2025
5-year range
$2.62 / $5.51
FY2021-FY2025
Trend
+37.5%
vs FY2024
Sector context
#80 of 163
Health Care
What the data says
At $5.51, Veracyte, Inc.'s working capital per share ranks #80 of 163 in the Health Care sector. Working Capital per Share has increased for 3 consecutive years, from $2.62 in FY2022 to $5.51 in FY2025.
Based on SEC 10-K filings.
5.51 in FY2025 with a 5-year CAGR of -5.3%.
Improved from $3.12 to $5.51 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +28.2%
- 5-Year CAGR
- -5.3%
- 10-Year CAGR
- -
Sector benchmark
#80 of 163 in Health CareTop 49% of 163This company $5.51 Sector average $23.91
▼
-77.0% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s working capital per share has grown for 3 consecutive years.
- In FY2025, working capital per share increased 37.5% year-over-year.
- Ranks #80 out of 163 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.51 | +37.5% |
| FY2024 | $4.01 | +28.5% |
| FY2023 | $3.12 | +19.2% |
| FY2022 | $2.62 | -14.9% |
| FY2021 | $3.07 | -57.5% |
| FY2020 | $7.23 | +73.6% |
| FY2019 | $4.17 | +67.6% |
| FY2018 | $2.48 | +100.2% |
| FY2017 | $1.24 | -44.7% |
| FY2016 | $2.24 | +52.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026